Shares of Clene Inc. (NASDAQ:CLNN – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among […]
Related Keywords
Davidj Matlin , John Henry Stevens , Investment Company Inc , Nasdaq , Vanguard Group Inc , Geode Capital Management , Cantor Fitzgerald , Securities Exchange Commission , Millennium Management , Clene Inc , Get Free Report , Director David , Director John Henry Stevens , Exchange Commission , Street Corp , Capital Management , Get Free , Multiple Sclerosis , Clene Daily , Clene , Nasdaq Clnn , Clnn , Medical , Ratings , Consensus ,
comparemela.com © 2020. All Rights Reserved.